Jay Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.05 Cr
as on 15-01-2025
- Paid Up Capital ₹ 2.04 Cr
as on 15-01-2025
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 73.81 Cr
as on 15-01-2025
- Satisfied Charges ₹ 1.30 M
as on 15-01-2025
- Revenue 10.63%
(FY 2021)
- Profit -1694.28%
(FY 2021)
- Ebitda -326.73%
(FY 2021)
- Net Worth -115.25%
(FY 2021)
- Total Assets -5.77%
(FY 2021)
About Jay Formulations
- CIN/LLPIN
U17119GJ1988PLC010855
- Company No.
010855
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 1988
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jay Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakshit Patel  | Managing Director | 19-Jan-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Komal Patel | Director | 24-Jun-2014 | Current |
| Aarjav Patel | Director | 24-Jun-2014 | Current |
Financial Performance of Jay Formulations.
Jay Formulations Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 10.63% increase. The company also saw a substantial fall in profitability, with a 1694.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 115.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Formulations?
In 2019, Jay Formulations had a promoter holding of 58.96% and a public holding of 41.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ace Learning And Counseling Private LimitedActive 19 years 11 monthsRakshit Patel is a mutual person
Charges (Loans)
₹73.81 Cr
₹0.13 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 63.00 Cr
- Sidbi : 7.80 Cr
- Tata Capital Financial Services Limited : 1.24 Cr
- The State Bank Of India : 0.89 Cr
- Others : 0.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2021 | Sidbi | ₹2.80 Cr | Open |
| 02 Jan 2021 | Tata Capital Financial Services Limited | ₹1.24 Cr | Open |
| 08 Sep 2020 | Others | ₹1.25 M | Open |
| 30 Jul 2020 | Others | ₹1.24 M | Open |
| 24 Jul 2020 | Sidbi | ₹2.80 Cr | Open |
How Many Employees Work at Jay Formulations?
Unlock and access historical data on people associated with Jay Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
